Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours.

Author List
Schöffski P, Gordon M, Smith DC, Kurzrock R, Daud A, Vogelzang NJ, Lee Y, Scheffold C, Shapiro GI
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1215756
Publication Year
2017
PubMed ID
29059635
Publication Title
Schöffski P, Gordon M, Smith DC, Kurzrock R, Daud A, Vogelzang NJ, Lee Y, Scheffold C, Shapiro GI. Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours. Eur J Cancer. 2017 11; 86:296-304.